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Dracaena cinnabari Balf.f. is a red resin endemic to Socotra Island, Yemen. Although there have been several reports on its
therapeutic properties, information on its cytotoxicity and anticancer effects is very limited. This study utilized a bioassay-guided
fractionation approach to determine the cytotoxic and apoptosis-inducing effects of D. cinnabari on human oral squamous cell
carcinoma (OSCC). The cytotoxic effects of D. cinnabari crude extract were observed in a panel of OSCC cell lines and were
most pronounced in H400. Only fractions DCc and DCd were active on H400 cells; subfractions DCc15 and DCd16 exhibited
the greatest cytotoxicity against H400 cells and D. cinnabari inhibited cells proliferation in a time-dependent manner. This was
achieved primarily via apoptosis where externalization of phospholipid phosphatidylserine was observed using DAPI/Annexin V
fluorescence double staining mechanism studied through mitochondrial membrane potential assay cytochrome 𝑐 enzyme-linked
immunosorbent and caspases activities revealed depolarization of mitochondrial membrane potential (MMP) and significant
activation of caspases 9 and 3/7, concomitant with S phase arrest. Apoptotic proteins array suggested that MMP was regulated
by Bcl-2 proteins family as results demonstrated an upregulation of Bax, Bad, and Bid as well as downregulation of Bcl-2. Hence,
D. cinnabari has the potential to be developed as an anticancer agent.
1. Introduction
Oral squamous cell carcinoma (OSCC) is the sixth common
malignancy in theworld [1], principally due to thewidespread
use of tobacco and alcohol [2]. Despite recent advances in
surgical and radio/chemotherapy protocols, the prognosis for
patients with OSCC remains poor, particularly for those with
late stage disease [3]. The discovery of new anticancer agents
from natural products offers a promising new approach for
the treatment of cancer, as it is hoped they may reduce the
burden of side effects [4].
Natural products serve as a platform for the design and
synthesis for many important new commercialized drugs
[5]. The discovery as well as evaluation of plant-derived
anticancer agents encompasses many steps, starting with
the authentication and extraction of the plant material,
followed by the separation and isolation of the constituents
of interest, characterization of the isolated compounds, and
quantitative evaluation [6]. Bioassay-guided fractionation
has been recognized as an important method in the attempt
to isolate pure biologically active compound from natural
sources. Each fraction produced is evaluated in a bioassay
system and only active fractions are further fractionated [7].
Dracaena cinnabari, also known as dragon’s blood, is a deep
red resin that has been used as a traditional medicine in
different cultures across the world. Locals of the Moomy city
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in Socotra Island have usedD. cinnabari as a sort of “cure-all”
to treat general wound healing, diarrhea, fevers, dysentery
diseases, and internal ulcers of mouth, throat, intestines, and
stomach [8]. Also, Yemeni people have used D. cinnabari as
a folk medicine to cure dysentery, diarrhea, hemorrhage, and
external ulcers [9]. With the latest technology, several active
compounds had been isolated from the resin of D. cinnabari
and these compounds have been reported to possess a wide
spectrum of therapeutic properties, including antioxidant
activity [10] and antimicrobial activity [11]. Anticancer activ-
ity against human bladder carcinoma cells has been reported
[12]; however, the anticancer effects of D. cinnabari have not
been thoroughly investigated.
In the present study we have utilized a bioassay-
guided fractionation approach to evaluate the cytotoxic and
apoptosis-inducing effects of D. cinnabari on OSCC cells.
Fractions were isolated which exhibited cytotoxic effects that
were selective against malignant cells compared to normal
cells and these effects were associated with the induction of
apoptosis, a depolarization mitochondrial membrane poten-
tial, translocation of cytochrome 𝑐 from mitochondria into
cytosol in H400 cells, and the activation of caspase 9. The
apoptosis through modulation on mitochondrial integrity
associated with Bcl-2 family proteins as well as cell cycle
arrest. These data highlight the potential of D. cinnabari as
an anticancer agent and provide a guide for future efforts to
develop more potent anticancer drugs.
2. Materials and Methods
2.1. Plant Materials. D. cinnabari was collected from the
Island of Socotra, Yemen. The plant samples were identified
and authenticated by the Environmental Protection Author-
ity of Yemen; Ministry of Water and Environment, Republic
of Yemen, gave permission to conduct the study on this plant
(Ethic number 2012  |).
2.2. Extraction and Isolation. The powdered resin of D.
cinnabari (50 g) was macerated with methanol (MeOH) (3
× 500mL) (Merck, Darmstadt, Germany). The resultant
extract was filtered using Whatman No. 1 filter paper (What-
man, England) and dried under vacuum to yield 28.0 g of
the extract. The stock solution D. cinnabari crude extract
(10mg/mL) was prepared by dissolving the extract in DMSO
and was then stored at −20∘C for future use.
2.3. Bioassay-Guided Isolation. The methanolic extract was
fractionated using vacuum liquid chromatographic (Merck,
Germany) flash column chromatography. The extract (9.0 g)
was fractionated on silica gel type H using VLC (4.0 × 25 cm,
100 g). The extract was then eluted with a solvent gradient
of hexane/ethyl acetate (10 : 0, 3 × 200mL; 9 : 1, 3 × 200mL;
8 : 2, 3 × 200mL; 7 : 3, 3 × 200mL; 6 : 4, 3 × 200mL; 1 : 1,
3 × 200mL; 4 : 6, 3 × 200mL; 3 : 7, 3 × 200mL; 2 : 8, 3 ×
200mL; 1 : 9, 1 × 200mL) and ethyl acetate/MeOH (100 : 0, 1
× 200mL; 9 : 1, 2 × 200mL; 7 : 3, 1 × 200mL; 1 : 1, 1 × 250mL;
0 : 100, 1 × 250mL). Similar eluents were pooled according
to their liquid chromatography mass spectrometry (LC-
MS) profile using Shimadzu UFLC-IT-TOFMS, into seven
fractions, DCa-DCg. Each fraction was dried under vacuum
before being used in cell based assays.
The active fractions (DCc and DCd) were then further
fractionated using preparative high performance liquid chro-
matography (HPLC) (Gilson GX-281/322 system) using a
Waters Novapak C
18
column (40 × 100mm, 6 𝜇m). Fraction
DCc was eluted at a flow rate of 12mLmin−1 over 120min.
The gradient elution started at 30% solvent (A) (acetonitrile
with 0.1% formic acid) and 70% solvent B (water with 0.1%
formic acid) for 5min.The gradient then changed as follows:
linear gradient from30% to 50% (A) over 43min; 50–70% (A)
in 33min; 70–100% in 15min; and finally an isocratic elution
of 100% (A) over 24min. Similar subfractions were pooled
according to their LC-MS profile into 16 subfractions, DCc1–
DCc16.
Fraction DCd was fractionated at a flow rate of
12mLmin−1 over 160min. The linear gradient used was as
follows: 20% A over 5min; 20–30% from 5 to 48min; then
30–50% A in 49min followed by 50–100% A in 38min; and
finally an isocratic elution of 100% (A) over 38min. Similar
subfractionswere combined according to their LC-MSprofile
into 18 subfractions, DCd1–DCd18.The extraction protocol is
summarized in Figure 1.
2.4. Cell Culture. Six human oral squamous cell carcinoma
(OSCC) cell lines and normal human oral fibroblast (NHOF)
cells used in this study were obtained from Professor Ian
Charles Paterson, Department of Oral Biology and Biomed-
ical Sciences, Faculty of Dentistry, University of Malaya.
The derivation and culture of the OSCC cell lines have
been described previously [13]. Briefly, OSCC cell lines were
cultured in T-75 cm2 culture flask (Corning, USA) containing
DMEM/F-12 (Nacalai Tesque, Japan), supplementedwith 10%
(v/v) fetal bovine serum (FBS) (JR Scientific, USA). Normal
human oral fibroblasts (NHOF) were cultured in DMEM
(Gibco, USA) supplemented with 20% (v/v) FBS. Cells were
grown at 37∘C with 5% CO
2
in a humidified atmosphere.
2.5. MTT Cytotoxicity and Proliferation Assay. The cytotoxi-
city of extract, fractions, and subfractions ofD. cinnabariwas
tested using microculture tetrazolium test (MTT) assays, as
previously described [14]. 1 × 104 OSCC cells were seeded
in 96-well microplate and cultured for 24 hours. Cells
were treated with extract, fractions, and subfractions of D.
cinnabari at a concentration range of 0 𝜇g/mL–30𝜇g/mL for
72 hours. Untreated cells were regarded as negative controls,
while cells treated with Cisplatin served as a positive control.
Then, 20𝜇L of freshly prepared MTT salt (5mg/mL) was
added into each well and incubated in dark for 4 hours. The
mediawere removed and replacedwith 150 𝜇LDMSOand the
plate incubated for 10 minutes at 37∘C to ensure all crystals
were dissolved. Absorbance readings for the measurement
and references wavelengths (575 nm and 650 nm, resp.) were
determined using Tecan Infinite M200 Pro ELISA plate
reader (Ma¨nnedorf, Switzerland). Inhibitory concentration
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Figure 1: Flow chart of extraction procedure for D. cinnabari.
(IC
50
), concentration required to reduce cell viability by 50%
as compared to the control cells, was determined.
In order to investigate whether the cytotoxic effects were
specific to the cancer cells, selectivity indices (SI) for the
studied compounds of D. cinnabari (DC extract, fractions
DCc andDCd, and subfractionsDCc15 andDCd16) were cal-
culated. Selectivity index is defined as the ratio of cytotoxicity
on normal human oral fibroblast cells to selected OSCC cells
(SI = IC
50
on NHOF cells/IC
50
on OSCC cells) [15].
In experiments to measure proliferation rates, H400 cells
were seeded in 96-well microplates as described above and
treated with studied compounds ofD. cinnabari (DC extract,
fractionsDCc andDCd, and subfractionsDCc15 andDCd16)
at IC
50
concentrations for 24, 48, and 72 hours prior to MTT
assay.
Percentage of cell viability was determined as follows:
% viable cells = (OD sample
OD control
) × 100, (1)
where OD is the optical density.
2.6. DAPI/Annexin V-FITC Fluorescence Double Staining.
Mode of cell death either apoptosis or necrosis was deter-
mined through DAPI/Annexin V-FITC fluorescence double
staining according to [16]. Briefly, 100 𝜇L of 1 × 105 cells/mL
of H400 cells was seeded in 96-well plate and incubated at
37∘C, 5%CO
2
overnight. Cells were then treated with studied
compounds of D. cinnabari (DC extract, fractions DCc and
DCd, and subfractions DCc15 and DCd16) at concentration
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of IC
50
for 24 hours. Untreated cells served as negative
controls.
After 24 hours of treatment, the medium in each well was
discarded and 100 𝜇L of PBS was added. The 96-well plate
was centrifuged at 3000 rpm for 1minute and the supernatant
was discarded. One hundred 𝜇L, five 𝜇L, and two 𝜇L of 1x
AnnexinV-FITC binding buffer, AnnexinV-FITC, andDAPI
(100 𝜇g/mL) stains were added into each well, respectively,
and incubation at room temperature in dark for 15 minutes
was carried out. ImageXpress Micro Widefield High Content
Screening System (Molecular Devices) was used to quantify
and calculate the percentage of the apoptotic cells.
2.7. DNA Fragmentation. DNA fragmentation was deter-
mined throughDNA laddering assay according to Ramasamy
et al. (2012) [7]. Briefly, 1 × 105 cells/mL of H400 cells
were seeded and treated with DC extract, fractions DCc and
DCd, and subfractions DCc15 and DCd16 of D. cinnabari
at concentration of IC
50
for 24, 48, and 72 hours. Plate
was incubated at 37∘C, 5% CO
2
and untreated cells were
used as negative control. After the treatment time point,
cells were then trypsinized and washed with ice-cold PBS.
Extraction of DNA was carried out using DNA extraction
kit (Vivantis, USA) according to manufacturer’s protocol.
Purified DNA was eluted with 20𝜇L of elution buffer and
centrifugation at 5000×g for 1 minute was carried out. DNA
was stored at −20∘C. For detecting the DNA ladder pattern,
the extracted DNA samples were run on 1.5% agarose gel in
tris-acetic acid-EDTA (TAE) buffer. DNA band was observed
and photographed usingMultiDoc-It Digital Imaging System
(UVP, Upland, CA, USA). Apoptosis induction was indicated
by the appearance of DNA ladder fragments of approximately
180–200 bp multiples on the agarose gel.
2.8. Caspase Activities. Caspase 3/7, caspase 8, and caspase 9
activities in D. cinnabari-treated H400 cells were measured
using caspase-Glo 3/7, caspase-Glo 8, and caspase-Glo 9
assay kits from Promega according tomanufacturer protocol.
Briefly, 100 𝜇L of 1 × 105 cells/mL of H400 cells was seeded
in a 96-well white plate and kept under 5% CO
2
at 37∘C for
24 hours. Cells were then treated with DC extract, fractions
DCc and DCd, and subfractions DCc15 and DCd16 of D.
cinnabari using IC
50
concentration for 24 hours. Untreated
cells were used as negative controls. MG132 inhibitor was
added for caspase 8 and caspase 9 assays. Briefly, caspase-
Glo buffer was thawed and equilibrated to room temperature
prior to use.This buffer was then used to dissolve lyophilized
caspase-Glo substrate and themixture was vortexed to obtain
a homogenous solution. Prior to the addition of caspase-Glo
reagent, culture plate was equilibrated to room temperature.
Then, 100 𝜇L of the reagent was added to each well and placed
on orbital shaker for 30 seconds. The plate was then further
incubated at room temperature for 2 hours in dark. The
luminescence signal was then measured using Tecan Infinite
M200 Pro ELISA plate reader (Ma¨nnedorf, Switzerland).
2.9. Cytochrome 𝑐 Detection. Quantification of cytochrome 𝑐
was carried out using cytochrome 𝑐 ELISA kit (Invitrogen,
USA) according to the manufacturer’s instructions. Briefly, 1
× 105 cells/mL ofH400 cells were seeded and treatedwithDC
extract, fractions DCc andDCd, and subfractions DCc15 and
DCd16 of D. cinnabari at concentration of IC
50
for 24 hours.
Untreated cells were used as negative control. After 24 hours
of treatment, cells were harvested and washed twice with
ice-cold PBS. The resulting cell pellets were stored at −80∘C
until they were used. Cell proteins were extracted using RIPA
lyses buffer (Bio Basic Canada INC, Canada) supplemented
with protease inhibitor, phosphatase inhibitor, and phenyl-
methylsulfonyl fluoride (PMSF) according to manufacturer’s
instructions. Cytochrome 𝑐 in cell extracts was quantified
using ELISAkit. Cytochrome 𝑐 at concentration of 0–5 ng/mL
was used as standard. Absorbance reading at 450 nm for
samples and standard was measured using Tecan Infinite
M200 Pro ELISA plate reader (Ma¨nnedorf, Switzerland).
Sample concentrations were determined using cytochrome 𝑐
standard curve and expressed as ng per mL.
2.10. Mitochondrial Membrane Potential. Mitochondrial
membrane potential was determined using JC-10 mitochon-
drial membrane potential assay kit (ABCAM, USA)
according to manufacturer’s instruction. Briefly, 90 𝜇L of
1 × 105 cells/mL of H400 cells was seeded in a 96-well
black colour plate and incubated at 5% CO
2
, 37∘C for 24
hours. Treatment was carried out by adding 10 𝜇L of 10
times concentrated IC
50
of DC extract, fractions DCc and
DCd, and subfractions DCc15 and DCd16 of D. cinnabari
for another 24 hours. Untreated cells were used as negative
control. Fluorescence intensity at excitation/emission
490 nm/525 nm for green colour and 490 nm/590 nm for
red colour were measured using Tecan Infinite M200 ELISA
plate reader (Ma¨nnedorf, Switzerland). Data was displayed
in the ratio of green over red colour.
2.11. Human Apoptotic Proteins Array. Involvement of apop-
totic proteins during apoptosis was determined through
apoptosis array using Human Apoptosis Antibody Array
kit (RayBiotech, GA, USA) according to the manufacturer’s
instructions. Briefly, 1 × 105 cells/mL of H400 cells were
seeded and treated with DC extract, fractions DCc and
DCd, and subfractions DCc15 and DCd16 of D. cinnabari
at concentration of IC
50
for 72 hours. Untreated cells were
used as negative control. After 72 hours of treatment, H400-
treated cells were harvested and spun down at 2500 rpm, 4∘C
for 5 minutes. Cells were washed twice with ice-cold PBS.
Centrifugation was carried out again at 2500 rpm, 4∘C for 5
minutes and supernatant was discarded. Cell proteins were
extracted and about 500 𝜇g of proteins from each sample
was incubated with the human apoptosis array overnight.
Chemiluminescence detections were carried out by scanning
the membrane on Odyssey Fc Imaging System (LI-COR,
USA).
2.12. Cell Cycle Analysis. Propidium Iodide Flow Cytometry
Assay Kit (Abcam, USA) was used to determine the effect of
DC extract, fractions DCc and DCd, and subfractions DCc15
and DCd16 ofD. cinnabari on H400 cell cycle phases. Briefly,
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Table 1: Cytotoxicity (IC
50
) of D. cinnabari crude extract and
Cisplatin on OSCC cell lines.
Cell lines IC50 ± SEM (𝜇g/mL)
a
D. cinnabari extract Cisplatin
H400 5.9 ± 0.35 4.1 ± 0.55
H103 6.0 ± 0.08 0.8 ± 0.12
H376 7.2 ± 0.16 0.6 ± 0.03
H357 9.0 ± 1.63 2.0 ± 0.12
H314 17.4 ± 1.56 7.0 ± 0.58
H413 19.2 ± 1.47 2.0 ± 0.26
aData are presented as mean of triplicate values ± SEM. IC
50
values
≤20 𝜇g/mL are considered cytotoxic.
1 × 105 cells/mL of H400 cells were seeded into a 6-well
plate and incubated at 37∘C, 5% CO
2
overnight. Cells were
treated with studied compounds of D. cinnabari using IC
50
concentration for 48 hours and 72 hours. After the treatment
time points, trypsinization of the cells was carried out. Then,
the cells were washed with PBS once and fixation of the
cells was carried out using 66% ethanol. The fixed cells were
stored at 4∘C for at least 2 hours. After centrifugation at
500×g for 5 minutes, the cells were washed with PBS prior
to staining. Two hundred 𝜇L of staining solution composed
of 1x PI and RNase was added to the cell suspension. The
cells were incubated in dark at 37∘C for 20 to 30 minutes and
flow cytometry analysis was carried out using MASCQuant
analyzer (Miltenyi Biotec, Germany).
2.13. Statistical Analysis. Datawere expressed asmean± SEM
in triplicate. Statistical analysis was performed using one-way
ANOVA (SPSS version 17). A 𝑝 value <0.05 was considered
statistically significant.
3. Results
3.1. Cytotoxic Activities of D. cinnabari Extract. The results
of preliminary cytotoxicity screening of D. cinnabari crude
extract towards sixOSCCcell lines are summarized inTable 1.
Cisplatin, a commonly used chemotherapeutic drug for the
treatment of oral cancer in clinical based research, was used
as positive control in these experiments. Based on the US
National Cancer Institute (NCI) guidelines, a crude extract is
generally considered to have in vitro cytotoxic activity if the
IC
50
value is ≤20𝜇g/mL, while for a pure compound the IC
50
value is ≤4 𝜇g/mL, following incubation between 48 and 72
hours [7, 17, 18]. The results demonstrated that D. cinnabari
crude extract was cytotoxic towards all the sixOSCC cell lines
as the IC
50
values ≤20𝜇g/mL. The strongest cytotoxic effect
was detected on H400 cells with an IC
50
value of 5.9 𝜇g/mL.
Therefore, H400 cells were selected as a targeted cell line
for further screening with fractions and subfractions of D.
cinnabari.
3.2. Bioassay-Guided Fractionation and Selectivity Index of
D. cinnabari. Vacuum liquid chromatography (VLC) of D.
cinnabari crude extract produced a total of seven fractions
Table 2: The yield (mg) obtained and cytotoxicity (IC
50
) for
fractions of D. cinnabari and subfractions DCc and DCd.
Fractions/subfractions Yield (mg) IC
50
± SEM (𝜇g/mL)a
DCab 3.4 29.0 ± 0.64
DCb 3.0 >30
DCc 7.0 5.8 ± 0.37
DCd 4.5 3.1 ± 0.13
DCe 4.5 18.4 ± 0.76
DCf 3.2 >30
DCg 3.9 >30
DCc1c 2.0 >30
DCc2 1.0 25.4 ± 0.38
DCc3 1.0 5.1 ± 1.40
DCc4 1.6 13.1 ± 0.47
DCc5 1.7 25.3 ± 0.18
DCc6 1.4 >30
DCc7 0.9 12.4 ± 0.26
DCc8 0.9 11.8 ± 0.23
DCc9 1.4 5.4 ± 0.16
DCc10 1.9 6.1 ± 0.09
DCc11 2.2 3.0 ± 0
DCc12 1.0 3.1 ± 0.04
DCc13 1.1 3.0 ± 0
DCc14 0.8 3.4 ± 0.07
DCc15 2.0 2.9 ± 0.07
DCc16 1.3 4.2 ± 0.16
DCd1d 1.0 >30
DCd2 0.7 27.9 ± 0.63
DCd3 1.8 20.7 ± 0.77
DCd4 1.5 12.8 ± 0.12
DCd5 0.8 22.3 ± 1.16
DCd6 1.2 27.6 ± 0.57
DCd7 1.3 23.8 ± 0.33
DCd8 1.6 17.8 ± 1.62
DCd9 2.8 5.6 ± 0.12
DCd10 1.0 3.9 ± 0.94
DCd11 2.0 3.1 ± 2.36
DCd12 2.0 3.2 ± 0.06
DCd13 1.5 4.0 ± 0.56
DCd14 1.7 5.0 ± 0.12
DCd15 2.4 3.3 ± 0.08
DCd16 2.0 2.9 ± 0.07
DCd17 2.0 3.9 ± 0.18
DCd18 2.0 13.2 ± 0.13
aData are presented as mean ± SEM in triplicate. Values in bold characters
are considered cytotoxically active towards H400 cells (IC
50
≤ 10𝜇g/mL for
fractions; IC
50
value ≤ 4𝜇g/mL for subfractions).
bDCa, DCb, . . ., DCg: fractions of D. cinnabari.
cDCc1, DCc2, . . ., DCc16: subfractions isolated from fraction DCc.
dDCd1, DCd2, . . ., DCd18: subfractions isolated from fraction DCd.
designated as DCa–DCg. The yield obtained and the cyto-
toxicity of fractions and subfractions against H400 cells are
summarized in Table 2. Fraction DCd exhibited the greatest
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Table 3: Cytotoxicity (IC
50
) against NHOF cells and selectivity
index (SI) of selected active extract, fractions, and subfractions of
D. cinnabari.
Selected compounds IC
50
± SEM (𝜇g/mL) SI
DC extracta >30 ND
DCcb >30 ND
DCdb >30 ND
DCc15c 24 ± 2.77 8.28
DCd16d >30 ND
Cisplatin >30 ND
Data are presented as mean ± SEM in triplicate. Selectivity index is defined
as the ratio of cytotoxicity (IC
50
values) on normal human oral fibroblast
(NHOF) cells to cancer cells (SI = IC
50
NHOF cells/IC
50
on H400 cells). SI
values greater than 3 are considered to have high selectivity towards cancer
cells.
ND: not detected (as the IC
50
values on NHOF >30𝜇g/mL).
aDC extract: methanol extract of D. cinnabari.
bDCc and DCd: fractions of D. cinnabari.
cDCc15: subfraction isolated from fraction DCc.
dDCd16: subfraction isolated from fraction DCd.
cytotoxic activity with an IC
50
value of 3.1 𝜇g/mL, followed by
fractions DCc, DCe, and DCa with IC
50
values in the range
5.8 𝜇g/mL to 29.0 𝜇g/mL. For fractions DCb, DCf, and DCg,
no cytotoxic effects can be observed as the IC
50
>30 𝜇g/mL.
Referring to a cut-off point of IC
50
≤10 𝜇g/mL as active
fractions [19], fractions DCc andDCdwere considered active
towards H400 cells and they were subjected for second step
of bioassay-guided fractionation.
A second step of bioassay-guided fractionation on frac-
tions DCc and DCd yielded a total number of 16 subfractions
(DCc1–DCc16) and 18 subfractions (DCd1–DCd18), respec-
tively. Among the 16 subfractions of DCc, only 5 subfractions
were cytotoxically active towards H400 cells with subfraction
DCc15 showing the highest cytotoxic effect (IC
50
values of
2.9 𝜇g/mL), whereas, among the 18 subfractions of DCd,
only 7 subfractions were cytotoxically active towards H400
cells with subfractionDCd16 exhibiting the greatest cytotoxic
effect (IC
50
values of 2.9 𝜇g/mL). Throughout the cytotoxi-
city screening with bioassay-guided fractionation approach,
crude extract (DC), fractionsDCc andDCd, and subfractions
DCc15 and DCd16 were selected as studied compounds for
further study to investigate their effects on apoptosis.
Selectivity indices (SI) were calculated to determine
whether the studied compounds of D. cinnabari exerted
selective cytotoxic effects towards cancer cells compared to
normal cells. In present study, SI value was determined
through the cytotoxic activity on NHOF cells (Table 3).
An SI value greater than 3 is considered to have high
selectivity towards cancer cells [15]. Results demonstrated
that subfraction DCc15 had IC
50
values of 24𝜇g/mL against
NHOF cells with SI value of 8.28. No IC
50
and SI values
can be recorded for extract, fraction DCd, fraction DCc,
and subfraction DCd16 as the IC
50
values >30 𝜇g/mL. Thus,
cytotoxicity activity of DC extract, fractions DCc and DCd,
and subfractions DCc15 and DCd16 was considered selective
towards H400 cancer cells.
Table 4: Percentage of apoptotic cells upon treatments with studied
compounds of D. cinnabari at concentration of IC
50
for 24 hours.
Studied compounds of
D. cinnabari Percentage of apoptotic cells (%)
DC 58.14
DCc 67.03
DCd 74.43
DCc15 85.69
DCd16 41.99
Negative control 13.81
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Figure 2: H400 cells proliferation upon treatment with DC extract,
fractions DCc and DCd, and subfractions DCc15 and DCd16 of
D. cinnabari at concentration of IC
50
for 24, 48, and 72 hours.
∗Significant difference as compared to negative control (𝑝 < 0.05)
when statistical analysis was performed using one-way ANOVA.
3.3. D. cinnabari Inhibits H400 Cell Growth. The effects
of IC
50
concentrations of DC extract, fractions DCc and
DCd, subfractions DCc15 and DCd16 on the proliferation
of H400 cells are shown in Figure 2. Results demonstrated
H400 cells treated with D. cinnabari compounds inhibited
H400 cells growth in a time-dependent manner as compared
to untreated cells.
3.4. D. cinnabari Induces Externalization of Phospholipid Phos-
phatidylserine. To investigate the mode of cell death, cells
were stained with Annexin V-FITC and DAPI. As shown
in Figure 3 only a small population of untreated H400 cells
exhibited green and brighter blue fluorescence dye due to the
Annexin V-FITC and DAPI binding. Most of the nuclei for
untreated H400 cells stained weakly with DAPI and the cells
showed clear evidence of cell-cell contact.
Most of the nuclei of H400 cells treated with DC extract,
fractions DCc and DCd, and subfractions DCc15 and DCd16
were stained stronger with DAPI conjugated with Annexin
V-FITC, indicating chromatin condensation and externaliza-
tion of phospholipid phosphatidylserine. In addition, H400
cells exposed to these compounds showed a reduction in
cell-cell contact as compared to untreated cells. Table 4
shows the percentage of apoptotic cells increased from 13.81%
(untreated cells) to a range of 41.99% to 85.69% following
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Figure 3: Morphological assessment of H400 cells treated with active DC extract, fractions DCc and DCd, and subfractions DCc15 and
DCd16. H400 cells were treated at concentration of IC
50
for 24 hours. Percentage of apoptotic cells was analyzed using ImageXpress Micro
Widefield High Content Screening System after staining with DAPI/Annexin V-FITC (magnification 10x).
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Figure 4: D. cinnabari induces apoptosis through intrinsic caspase
pathway. Luminescence intensity of caspases 3/7, 8, and 9 in
H400 cells treated with DC extract, fractions DCc and DCd, and
subfractions DCc15 and DCd16 of D. cinnabari at concentration of
IC
50
for 24 hours. Untreated cells were used as negative control. Data
was expressed as mean ± SEM (𝑛 = 3). ∗Significant difference as
compared to negative control (𝑝 < 0.05) when statistical analysis
was performed.
treatments of H400 cells with D. cinnabari extract and
fractions.This revealed that themode of cell death induced by
DC extract, fractions DCc and DCd, and subfractions DCc15
and DCd16 was via apoptosis.
3.5. D. cinnabari Induces Internucleosomal DNA Fragmenta-
tion. Characteristic oligonucleosomal DNA fragments (lad-
ders) were not observed in H400 cells treated with DC
extract, fractions DCc andDCd, and subfractions DCc15 and
DCd16 for the first 24 hours and 48 hours. However, at 72
hours, formation of DNA ladder was slightly observed on
the 1.5% agarose gel. DNA isolated from untreated cells at 72
hours did not show any ladder formation. Hence, the efficient
induction of apoptosis was observed at 72 hours inH400 cells
treated with IC
50
concentration of DC extract, fractions DCc
and DCd, and subfractions DCc15 and DCd16.
3.6. D. cinnabari Induces Apoptosis through Intrinsic Cas-
pase Pathway. Apoptosis induction through either intrinsic
or extrinsic pathways in H400 cells treated with studied
compounds of D. cinnabari was examined by assessing the
intracellular level of caspase 3/7, caspase 8, and caspase 9
activities (Figure 4). The results demonstrated that caspase
3/7, caspase 8, and caspase 9 were found to be enhanced
upon the treatment with DC extract, fraction DCd, and
subfractions DCc15 and DCd16 of D. cinnabari. The highest
increment in RLU was observed in caspase 3/7 activity,
followed by caspase 9 and caspase 8. This indicates that
caspase 9 played a significant role as an initiator caspase to
initiate the intrinsic apoptosis pathway following treatment
with D. cinnabari.
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Figure 5: Changes in mitochondrial membrane potential in H400
cells treated with DC extract, fractions DCc and DCd, and subfrac-
tions DCc15 and DCd16 of D. cinnabari. H400 cells were treated
at concentration of IC
50
for 24 hours. Untreated cells were used
as negative control. Data was expressed as mean ± SEM (𝑛 = 3).
∗Significant difference as compared to negative control (𝑝 < 0.05)
when statistical analysis was performed.
3.7. Cytochrome 𝑐 Detection. H400 cells treated with DC
extract, fractions DCc and DCd, and subfraction DCd16 for
24 hours showed slight increase in cytochrome 𝑐 compared
to untreated cells. The cytochrome 𝑐 concentration increased
from 98.92 ± 0.93 ng/mL (control) to a range of 99.13 ±
0.40 ng/mL to 100.12 ± 1.38 ng/mL. However, H400 cells
treated with subfraction DCc15 showed slight decrease in
cytochrome 𝑐 concentration (98.73 ± 0.81 ng/mL). Thus,
studied compounds fractionated from D. cinnabari triggered
the translocation of cytochrome 𝑐 frommitochondrial mem-
brane into cytosol in H400 cells.
3.8. D. cinnabari Induces Depolarization of Mitochondrial
Membrane Potential (MMP). Mitochondrial permeability
transition is an important step in the induction of cellular
apoptosis. Loss of mitochondrial potential (depolarization)
is a classical evidence of apoptosis. In present study, H400
cells treated with DC extract, fractions DCc and DCd, and
subfractions DCc15 and DCd16 of D. cinnabari for 24 hours
showed increment in the ratio of green/red fluorescent inten-
sity ranging from 1.81 RLU to 4.14RLUcompared to untreated
cell (0.44 RLU). Mitochondrial membrane potential was
reduced in H400 cells and the reduction was significant
for fraction DCd and subfraction DCd16 (𝑝 < 0.05). This
shows that the studied compounds of D. cinnabari induced
depolarization of the mitochondrial membrane potential
during apoptosis (Figure 5).
3.9. Apoptotic Proteins Array. Semiquantitative evaluations
of apoptotic proteins in H400 cells treated with studied com-
pounds of D. cinnabari for 72 hours at concentration of IC
50
were determined through human apoptotic proteins array.
The signal intensity for each antigen-specific antibody spot
is proportional to the relative concentration of the antigen in
the sample. Figure 6 showed that the positive control signal
on each array image has similar intensities. Hence, com-
parison of signal intensities for individual antigen-specific
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Figure 6: Human apoptotic proteins array for (a) untreated H400 cells; cells treated at concentration of IC
50
with (b) DC extract, (c) fraction
DCc, (d) fraction DCd, (e) subfraction DCc15, and (f) subfraction DCd16 for 72 hours.
antibody spots among the array membranes can be used to
determine differences in relative protein expression.
In present study, H400 cells treated with DC extract,
fractions DCc and DCd, and subfractions DCc15 and DCd16
demonstrated upregulation of proapoptotic proteins such
as Bax, Bad, and Bid and downregulation of antiapoptotic
protein, Bcl-2. Besides, the elevation in the expressions of
cytochrome 𝑐 and SMAC inH400-treated cells was consistent
with the earlier assay results which reported depolarization
of the mitochondrial membrane potential leading to the
translocation of these proteins into cytosol. Upregulation of
both caspase 3 and caspase 8 further confirmed the previous
results as demonstrated in caspases assay. In addition, there
was an increment in TRAIL-R1 and TRAIL-R2 in H400 cells
upon treatment with DC extract, fractions DCc and DCd,
and subfractions DCc15 and DCd16.
3.10. D. cinnabari Causes Cell Cycle Arrest in S phase. The
effect of D. cinnabari extract and fractions on the regulation
of cell cycle was carried out using flow cytometry (Figure 7,
Table 5). Compared with untreated H400 cells, the studied
compounds of D. cinnabari resulted in a significant increase
in H400 cells number in S phase upon 48 and 72 hours of
treatment (𝑝 < 0.05). Additionally, the results demonstrated
that the D. cinnabari extract and fractions showed a signif-
icant time-dependent increase in the proportion of sub-G1
phase, indicating apoptotic cells.
4. Discussion
The prognosis for patients diagnosed with OSCC remains
very poor and new strategies for managing the disease are
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Table 5: Cell cycle analysis of H400 cells at 48 and 72 hours treated with studied compounds of D. cinnabari at concentration of IC
50
.
Compounds Percentage of cells (%)
Sub-G1 G1 S G2/M
48 hours
Negative control 2.86 ± 0.27 63.52 ± 1.42 3.91 ± 0.05 17.11 ± 0.09
DC extract 27.87 ± 0.79∗ 35.13 ± 0.62∗ 5.21 ± 0.10∗ 10.47 ± 0.17∗
DCc 29.78 ± 0.92∗ 24.89 ± 0.43 5.90 ± 0.22∗ 13.21 ± 0.36∗
DCd 30.28 ± 0.74∗ 33.09 ± 0.50∗ 5.47 ± 0.06∗ 12.51 ± 0.22∗
DCc15 5.16 ± 0.23 62.31 ± 1.05∗ 4.52 ± 0.06∗ 13.37 ± 0.12∗
DCd16 26.33 ± 0.44∗ 43.40 ± 1.14∗ 6.93 ± 0.10∗ 12.96 ± 0.17∗
72 hours
Negative control 7.00 ± 2.40 88.04 ± 1.16 2.27 ± 0.60 2.66 ± 1.55
DC extract 64.2 ± 7.19∗ 24.34 ± 2.71∗ 7.95 ± 2.32∗ 3.18 ± 2.38
DCc 56.45 ± 2.61∗ 30.57 ± 7.90∗ 8.08 ± 3.52∗ 4.32 ± 3.40
DCd 59.8 ± 7.36∗ 26.03 ± 3.06∗ 10.18 ± 1.91∗ 3.93 ± 2.48
DCc15 21.43 ± 7.59 70.69 ± 2.30∗ 5.32 ± 3.71∗ 2.28 ± 2.04
DCd16 68.43 ± 4.38∗ 22.56 ± 2.52∗ 7.46 ± 1.26∗ 1.59 ± 0.93
The values are expressed as mean ± SEM in triplicate. ∗Significant difference compared to negative control with 𝑝 < 0.05 through one-way ANOVA.
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Figure 7: Flow cytometric analysis of cell cycle distribution in
H400 cells. H400 cells were treated with DC extract, fractions DCc
and DCd, and subfractions DCc15 and DCd16 of D. cinnabari at
concentration of IC
50
for 48 and 72 hours. Untreated cells were used
as negative control. Data was shown as mean ± SEM. ∗Significant
difference as compared to negative control (𝑝 < 0.05) when
statistical analysis was performed.
required. Screening natural products for anticancer effects
represents one way to identify new therapeutic agents. D.
cinnabari has been used to treat a variety of conditions by
the people from the Moomy city in Socotra Island and in
Yemen and it has been shown to possess a variety of biological
properties, including antioxidant and antimicrobial effects
[11, 20]. The present study has examined for the first time the
anticancer effects of D. cinnabari against OSCC.
Based on NCI guidelines, a crude extract with IC
50
value
≤20𝜇g/mL and SI value >3 is considered to have strong
cytotoxicity and is highly specific to cancer cells [7, 15, 17, 18,
21]. In the present study, a methanolic extract of D. cinnabari
demonstrated marked cytotoxicity towards OSCC cell lines,
results which are consistent with those of Al-Fatimi et al.
(2005) [12] who showed anticancer effects on bladder cancer
cells. Together, these data suggest that compounds from D.
cinnabari may serve as promising new anticancer agents.
Therefore, we carried out bioassay-guided fractionation onD.
cinnabari to identify fractions that are capable of inhibiting
the growth of OSCC cancer cells. To carry out the bioassay-
guided fractionation, H400 cell lines were selected as a target
cell line for further cytotoxic screening with fractions and
subfractions of D. cinnabari as it was most sensitive to the
effects of the crude extract (IC
50
5.9 𝜇g/mL). Fractionation of
the methanolic extract ofD. cinnabari yielded a total number
of 7 fractions. To narrow the selection of active fractions that
have the ultimate potential for biopharmaceutical use, a cut-
off point of IC
50
≤10 𝜇g/mL was applied in this study. A
similar approach was used by Siti Syarifah et al. (2011) [19],
to identify cytotoxic fractions from Cerbera odollam using
a bioassay-guided fractionation approach. In the present
study, using this cut-off point, 2 out of 7 fractions were
considered cytotoxically active towards H400 cells. These
2 active fractions, fractions DCc and DCd, were subjected
for further fractionation using preparative high performance
liquid chromatography (HPLC) to yield subfractions. A total
number of 16 and 18 subfractions were isolated from fractions
DCc and DCd, respectively. Subfractions DCc15 and DCd16
were the most active subfractions among the subfractions
of DCc and DCd, respectively. NCI guidelines set a limit
of IC
50
≤4 𝜇g/mL for a pure compound to be considered
active [17]. Hence, both subfractions DCc15 and DCd16 were
considered cytotoxically active towardsH400 cells as the IC
50
values≤4 𝜇g/mL.The variation in the IC
50
values between the
fractions and subfractions of D. cinnabari was likely a result
of different phytochemical constituents, the specific identity
of which will form the basis of a future study.
An ideal anticancer drug should kill or incapacitate
cancer cells without causing excessive damage to normal cells
BioMed Research International 11
[22]. A selectivity index (SI) value is used as a reference
point to determine whether the cytotoxic effect was specific
towards cancer cells. SI values greater than 3 were considered
to have high selectivity towards cancer cells [15]. Our results
demonstrated that DC extract, fractions DCc and DCd, and
subfractions DCc15 and DCd16 were specific towards H400
cells. These findings further highlight the potential of D.
cinnabari to be developed as an anticancer drug.
There are two recognized modes of cell death, apoptosis
and necrosis [23], and many studies have shown that the
mechanism of action for anticancer drugs is based on
the induction of apoptosis [7]. Externalization of phos-
phatidylserine (PS) from inner layer to outer layer of the
cell membrane is the first indicator of apoptosis [24]. In
present study, the presence of apoptotic cells was observed
using Annexin V-FITC and DAPI fluorescence double stain-
ing. Annexin V-FITC binds to the externalization of PS
and fluorescent green [16], whilst DAPI stain is used for
counterstaining the nuclei of cells which fluorescence blue
colour [25, 26]. The intensity of DAPI labeling represents
the status of chromatin condensation; pale uniform DAPI
staining indicated a normal and uncondensed chromatin,
while brighter DAPI stain revealed a condensed chromatin
which is a feature of apoptosis [27]. Our results suggested that
the DC extract, fractions DCc and DCd, and subfractions
DCc15 and DCd16 induced apoptosis in H400 cells, as the
treated cells were stained with Annexin V-FITC and brighter
DAPI stains which indicated externalization of PS conjugated
and chromatin condensation, showing an increase in the
percentage of apoptotic cells compared to untreated cells.
Important feature of cell apoptosis is the fragmentation
of genomic DNA into integer multiples of 180–200 base
pairs (bp) unit producing characteristic ladder on agarose gel
electrophoresis. Activation of an endogenous endonuclease
cleaves DNA in the linker region between histones on the
chromosomes. Since the DNA wrapped around the histone
comprises 180–200 bp, many of these intervals are character-
istically observed and are commonly referred to as apoptotic
ladder [7]. In present study, conventional agarose gel elec-
trophoresis method was used in present study to analyze and
observe the fragmented nuclei inH400 cells under ultraviolet
light. Results demonstrated that no fragmentation of DNA
was observed at 24, 48, and 72 hours of treatmentwith studied
compounds of D. cinnabari on H400 cells. Fragmentation of
DNA has been seen in many cell types and it is generally
considered as the biochemical hallmark of apoptosis. Yet, it
may be delayed, partial, or absent in some cell types [25].
Identification of apoptosis based on DNA laddering has led
to an argument as some cells show apoptotic morphological
changes in the absence of DNA fragmentation, making
the formation of DNA ladders solely used as a marker of
apoptosis unsuitable [28–30]. Degradation of DNA may be
characteristic but not necessary for the sequence of events
leading to apoptosis. There was no clear evidence presented
to date that degradation of DNA would play a primary and
causative role in apoptotic cell death. Besides, study byGooch
and Yee (1999) stated that DNA laddering represented a late
event in the progression to apoptotic cell death and was not
related to the ability of cancer cells to undergo apoptosis
[30]. In addition, the absence or less expression of DNA
fragmentation factor (DFF) in the cells could be a reason
why the apoptotic ladder formation was not observed as this
factor is essential for the apoptotic ladder formation [31]. In
contrast, recent reports have described that electrophoresis
technique in the detection of apoptosis was not very suitable
for quantitative studies. High level of necrosis or the rapid
onset of secondary necrosis may mask the ladders produced
by low levels of apoptotic cell. Moreover, the possibility that
induction of necrosis could generate ladder patterns on gel
electrophoresis could not be ruled out [32]. These might
explain the reasons why apoptotic ladder was not observed
in H400 cells in this study.
Apoptosis can be an extrinsic pathway mediated via
activation of death receptors or by an intrinsicmitochondria-
mediated pathway [33]. Mitochondria play an important role
in the regulation of apoptosis [34]. Fluorescent probes are
tools frequently used to assess the mitochondrial function by
monitoring the mitochondrial membrane potential (Δ𝜓𝑚)
[35]. In the present study we used JC-10 as a ratiometric
fluorescent probe which was capable of entering selectively
into mitochondria and changed reversibly its colour from
green to orange asmembrane potential increases.We demon-
strated for the first time that the DC extract, fractions
DCc and DCd, and subfractions DCc15 and DCd16 induced
depolarization ofmitochondrialmembrane potential (MMP)
in H400 cells. Therefore, one of the first steps by which the
studied compounds of D. cinnabari trigger apoptosis is likely
to be through changes in MMP. Depolarization of MMP
causes the release of cytochrome 𝑐 into cytosol which then
leads to the activation of caspase 9 through the formation
of apoptosome and subsequent cleavage of effectors caspase
3/7 [36]. In present study, treatment of H400 cells with
the DC extract, fractions DCc and DCd, and subfractions
DCc15 and DCd16 resulted in an increase in caspase 3/7 and
caspase 9 activities, with a reduced and more variable effect
on the activity of caspase 8.These data indicate that caspase 9
played a significant role as an initiator caspase to initiate the
intrinsic apoptosis pathway. Taken together, our data strongly
indicate that the studied compounds of D. cinnabari induced
apoptosis via the intrinsic pathway by depolarisingMMP and
subsequent activation of downstream caspases.
In addition, changes in MMP cause the translocation of
cytochrome 𝑐 from the intermembrane space of the mito-
chondrial into cytosol [37]. Therefore, the intracellular level
of cytochrome 𝑐 in H400 cells was examined, using ELISA.
TreatedH400 cells showed a slight increment in cytochrome 𝑐
concentration but the increment was not statistically different
compared to untreated cells. This could be because of the
cytochrome 𝑐 that was just initiated to be released in H400
cells at 24 hours of treatment. Increasing the assay time to 48
and 72 hours of treatment might be necessary to detect more
marked levels of cytochrome 𝑐 translocation. The release
of cytochrome 𝑐 into the cytosol upon depolarization of
mitochondrial membranes leads to the activation of caspase
9 through the formation of the apoptosome. Subsequent
activation of the initiator caspase 9 causes the cleavage
of effectors caspase 3/7 [38]. The significant increment of
caspases 9 and 3/7 in present study provides evidence that the
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apoptosis induced by studied compounds of D. cinnabari in
H400 cells was a caspase-dependent event.
There is growing evidence that Bcl-2 family proteins,
which comprise proapoptotic and antiapoptotic proteins, are
required in the modulation of mitochondrial integrity. The
ratio of pro- to antiapoptotic proteins has been suggested to
play an important role in determining commitment to cell
death [39]. In present study, regulation of these apoptotic
proteins was observed through apoptotic proteins array.
Results demonstrated upregulation of proapoptotic proteins
(Bad, Bax, and Bid) together with a downregulation of anti-
apoptotic protein (Bcl-2). Bad interacts with antiapoptotic
proteins (Bcl-2) to ablate their prosurvival function which
then allows the activation of Bax and Bak [40, 41]. An earlier
study reported that activation of Bax and Bak caused the
loss of mitochondrial membrane potential [42]. In addition,
activation of Bax or Bak caused them to oligomerize in the
outer mitochondrial membrane to generate large pores that
released cytochrome 𝑐 into cytosol [43]. Taken together, the
results from the apoptotic proteins array which documented
an upregulation of Bad and Bax and downregulation of Bcl-
2 were concurred with the previous results that showed
MMP depolarization as well as the release of cytochrome 𝑐
and SMAC into cytosol of H400 cells treated with studied
compounds of D. cinnabari.
Cell cycle, also known as cell division cycle, is a series of
events which lead to cell division and duplication [44, 45].
Any dysregulation of the cell cycle machinery will lead to the
development of cancers. The induction of cell cycle arrest at
a specific checkpoint and thereby inducing apoptosis are a
common mechanism for the cytotoxic effects of anticancer
drugs [20]. It had been reported that many anticancer agents
arrest cell cycle at G0/G1, S, or G2/M phase and then induced
apoptosis cell death [46, 47]. Our data suggested that the
studied compounds isolated fromD. cinnabari arrestedH400
cell at S phase after 48 and 72 hours of treatment. Interestingly,
arrest of H400 cells at G2/M phase was observed only at
72 hours of treatment with DC extract and fractions DCc
and DCd. Arrest of H400 cells in S and G2/M phases was
accompanied with large accumulation of H400 cells in the
sub-G1 phase. This proposed the relationship between H400
cells arrest at S and G2/M phases and apoptosis.
In summary, this study demonstrates for the first time
that theDCextract, fractionsDCc andDCd, and subfractions
DCc15 and DCd16 ofD. cinnabari showed selective cytotoxic
towards H400 cells, compared to normal human oral fibrob-
last (NHOF) cells. Furthermore, these compounds were able
to arrest H400 cells in S phase and G2/M phase and inhibited
the proliferation of H400 cells. Besides, studied compounds
ofD. cinnabari induced apoptosis through the depolarization
of mitochondrial membrane potential by downregulation of
Bcl-2 and upregulation of Bax, Bad, and Bid, which trigger
the translocation of cytochrome 𝑐 and SMAC into cytosol of
H400 cells. It is then followed by the activation of initiator
caspase 9 and executioner caspase 3/7 which lead to the
fragmentation of DNA. This form of apoptosis is associated
with the extrinsic pathway through the activation of caspase
8 and Bid cleavage. In conclusion, our results highlight the
potential of D. cinnabari to be developed as an anticancer
agent.
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